The latest news updates from the 2024 Symposium
Carsten F.J. Bakhuis discusses a Thursday evening poster presentation on worse prognosis for breast cancer in the second and third trimesters of pregnancy and shortly postpartum.
Neelima Vidula, MD, discusses a Thursday evening poster presentation on immune related adverse events in patients over 65 years of age vs. those younger than 65 years with breast cancer who were treated with immunotherapy.
Erika Hamilton, MD, discusses a Thursday evening poster presentation on the activity of ARV-471 in combination with a CDK4/6 inhibitor in patients with HR+ metastatic breast cancer.